RATE OF DRUG RESISTANCE MYCOBACTERIUM TUBERCULOSIS IN TOTAL NUMBER OF TUBERCULOSIS CASES
Abstract
In ihis article presents an analysis of the literature on the study of drug resistance of M. tuberculosis and their proportion in the etiology of tuberculosis. At present tuberculosis often caused by multiclrug-resistant (MDR) or extensively drug-resistant (Xl)R) strains of Mycobacterium tuberculosis.
Keywords:
Mycobacterium tuberculosis, tuberculosis, drug resistanceReferences
1. WHO Report 2009 Global tuberculosis control, surveillance, planning, financing: A Short Update to the 2009- Report World Health Organization, 2009.-R 411.
2. Национальный центр фтизиатрии при М3 КР Борьба с туберкулезом в КР 20 лет - итоги: статистический сборник.-Бишкек. Национальный центр фтизиатрии, 2011. -С. 42.
3. Егоров А М Достижения фундаментальных наук и новые подходы к химиотерапии туберкулеза // Проблемы туберкулеза. -2000. - №5. -С. 11-15.
4. Raviglione МС, Smith IM XDR tuberculosis—implications for global public health. N Engl J Med -2007. -P 656-659.
5. Ганза В II., Свисгунова В.П., Канин Е.С. Лекарственно резистентный туберкулез: проблемы ведения лечения // Дальневосточный медицинский журнал.-2005.-№ 4 -С 108-110.
6. WHO Global report on surveillance and response 2010. Multidrug and extensively drug- resistant ТВ (M/XDR-TB) Report World Health Organization, 2 0 10.-P 71
7. BottgerEC, Springer B. Tuberculosis: drug resistance, fitness, and strategies for global control // Eur J Pediatr - 2008, 167.-P. 141-148.
8. Meacci F, Orru G, Iona E et al. Drug resistance evolution of Mycobacterium tuberculosis strain from a noncompliant patient // J Clin Microbiol -2005,43: 3.-P.114-3120.
9. ShcherbakovD,AkbergenovR,MattT etal Directed mutagenesis of Mycobacterium smegmatis 16S rRNA to reconstruct the m-vivo evolution of aminoglycoside resistance in Mycobacterium tuberculosis /7 Mol Microbiol -2010, 77.-P 830-840
10. Boehme СС, Nabeta Р, Hillemann D. et al. Rapid molecular detection of tuberculosis and rifampin resistance // N Engl J Med - 2010;363(11): 1005-15.
11. McNerney R , Kiepiela P., Bishop K.S.et al. Rapid screening of Mycobacterium tuberculosis for susceptibility to rifampicin and streptomycin //Int. J. Tuberc'Lung Dis. -2000.-№ 4-P 69-75
12. Herrera L., Jimenez S., Valverde A.et al. Molecular analysis of rifampicin-resistant Mycobacterium tuberculosis isolated in Spain (1996—2001). Description of newmutations in the rpoB gene and review of the literature // Int. J Antimicrob. Agents.-2003.-№ 21 ,-P 403-408.
13. Jiao W W, Mokrousov I, Sun G Z, et al. (2007). Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing. China.//Chin Med J (Engl). -2007.120(9). -P.814-819.
14. Valvatnell, SyreH, KrossM, etal. (2009). Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing//J AntimicrobChemother. -2009, 64(4).-P. 694-701.
15. Kim HR, Hwang SS, Kim HJ et al Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis //Clin Infect Dis- 2007, 45(10). -P. 1290-5.
16. El Khechine A, Henry M, Raoult D et al Detection of Mycobacterium tuberculosis complex organisms in the stools of patients with pulmonary tuberculosis. Microbiology -2009, 155(Pt 7).-P.2384-9.
17. ВолошинаЕ.П., ХудушинаТ.А, Маслакова М.Г. et al. Лекарственная устойчивость микобактерии туберкулеза у впервые выявленных больных туберкулезом легких//Проблемы туберкулеза и болезней легких,-2005.-№ 12.-С.37-39.
18. Gandhi NR, Nunn Р, Dheda К. et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis // Lancet. -2010;375(9728).-P 1830.
